Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Immune system synthesis

The finding that the anthelmintic thiazoloimidazole levamisole showed immunoregulatory activity spurred further investigation of this heterocyclic system. Synthesis of a highly modified analogue starts by displacement of bromine in keto ester 149 by sulfur in substituted benzimidazole 148. Cyclization of the product (150), leads initially to the carbinol 151. Removal of the ester group by saponification in base followed by acid-catalyzed dehydration of the carbinol affords the immune regulator tilomisole (152) [28]. [Pg.217]

Cytokines. Figure 1 Inhibition of cytokine synthesis during activation of the specific immune system. The monoclonal antibodies Muromonab and Basiliximab are specific for the CD3 complex of the T-cell receptor, and for the IL-2 receptor on lymphocytes, respectively. Cyclosporin and Tacrolimus inhibit activation of cytoplasmic NF-AT, a transcription factor essential for activation of the IL-2 gene ( NFAT Family of Transcription Factors). Sirolimus interferes with mTOR signaling and inhibits IL-2 dependent proliferation. Red pharmaka, blue target proteins. [Pg.412]

Cole et al. (1995) reported on knock-out mice with a germ line deletion of GR. They demonstrated that lack of GR leads to perinatal death, atelectasis of the lung, and lack of adrenalin synthesis. To circumvent perinatal lethality, Tranche et al. (1999) and Brewer et al. (2003) generated tissue-specific somatic deletions of GR. This allowed to characterize GR function in the CNS, the immune system, and the liver in more detail. In particular, these approaches revealed novel aspects of organ-specific glucocorticoid physiology such as anxiety-like behavior, growth control, and polyclonal T cell activation. [Pg.546]

Science 200T,21(5512) 2263. (This issue contains a special section entitled Carbohydrates and Glycobiology. It contains articles on the synthesis, structural determination, and functions of sugar-containing molecules and the roles of glycosylation in the immune system). [Pg.534]

Table 9.5 The major cellular sources of human TNF-p. As is evident, TNF-a synthesis is not restricted to cells of the immune system, but is undertaken by a wide variety of different cells in different anatomical locations, including the brain... Table 9.5 The major cellular sources of human TNF-p. As is evident, TNF-a synthesis is not restricted to cells of the immune system, but is undertaken by a wide variety of different cells in different anatomical locations, including the brain...
After this initial phase of infection subsides, the free viral load in the blood declines, often to almost undetectable levels. This latent phase may last for anything up to 10 years or more. During this phase, however, there does seem to be continuous synthesis and destruction of viral particles. This is accompanied by a high turnover rate of (CD4+) T-helper lymphocytes. The levels of these T-lymphocytes decline with time, as does antibody levels specific for viral proteins. The circulating viral load often increases as a result, and the depletion of T-helper cells compromises general immune function. As the immune system fails, classical symptoms of AIDS-related complex (ARC) and, finally, full-blown AIDS begin to develop. [Pg.408]

Fig. 7.3. Osteoclastogenesis after estrogen deficiency. Estrogen deprivation leads to an increase in the synthesis of RANKL for stromal/OB cells of the BM. This increase in the expression of RANKL leads to an increase in OCS. Estrogen deficiency also induces the synthesis and secretion of cytokines, such as IL-6 and M-CSF, that increase the number of preosteoclasts in the BM, and thus increases OCS. Nonetheless, certain cells of the immune system, such as monocytes and T-cells, intervene in the process when the supply of estrogens fails. These cells secrete IL-1 and TNF-a that are powerful inductors of OCS. When estrogens or agonists of estrogen receptors like raloxifene are administered, the synthesis and secretion of many of the mentioned cytokines diminish and the synthesis and liberation of OPG and TGF-/S are stimulated. These molecules inhibit OCS by inhibiting the RANKL/RANK signal pathway and by promoting osteoclast apoptosis... Fig. 7.3. Osteoclastogenesis after estrogen deficiency. Estrogen deprivation leads to an increase in the synthesis of RANKL for stromal/OB cells of the BM. This increase in the expression of RANKL leads to an increase in OCS. Estrogen deficiency also induces the synthesis and secretion of cytokines, such as IL-6 and M-CSF, that increase the number of preosteoclasts in the BM, and thus increases OCS. Nonetheless, certain cells of the immune system, such as monocytes and T-cells, intervene in the process when the supply of estrogens fails. These cells secrete IL-1 and TNF-a that are powerful inductors of OCS. When estrogens or agonists of estrogen receptors like raloxifene are administered, the synthesis and secretion of many of the mentioned cytokines diminish and the synthesis and liberation of OPG and TGF-/S are stimulated. These molecules inhibit OCS by inhibiting the RANKL/RANK signal pathway and by promoting osteoclast apoptosis...
The anticonvulsant phenytoin, and to a lesser degree carbamazepine, can inhibit the synthesis of antibodies, and in some cases these drugs can result in lymphoproliferation [77-79]. These effects on the immune system could be viewed as a type of autoimmunity. The relationship between such effects and autoimmunity are still not clear, although the more recent observations that cytokines and anti-cytokines can cause autoimmunity support the existence of such a relationship. The previous edition of this book contained an extensive discussion of the possible relationship between immunosuppression and autoimmunity [80], Phenytoin and carbamazepine can also cause a lupus-like syndrome although the incidence is lower than with many other drugs. [Pg.460]

Other Factors. ECT no doubt destroys the homeostasis of the cancerous cells by profoundly disturbing their microenvironment and by dismantling their structure. It might also lead to the inhibition of their DNA synthesis. It has been speculated that ECT might release the Tumor Necrosis Factor (TNF) or, somehow super-activate the immune system at the tumor site. [Pg.491]

The classical cellular sources of histamine are mast cells and basophils, gastric enterochromaffin-like cells, platelets and histaminergic neurons. Interestingly the cells in the immune system, which do not store histamine, show high HDC activity and are capable of production of high amounts of histamine, which is secreted immediately after synthesis [20]. These cells include platelets, monocytes/macrophages, DCs, neutrophils, and T and B lymphocytes. [Pg.70]

More than a decade ago, it became clear that the human body makes NO. It is made in the brain, in the muscle cells which exist in the interior of the blood vessels, by macrophages (white cells that form an important part of the immune system), by the corpus cavemosum of the penis, and perhaps elsewhere. NO plays an important role in each of these tissues. The source of the atoms for the synthesis of NO is the common amino acid arginine (chapter 9). Under the influence of an enzyme termed NO synthase, arginine is converted to NO (and other products). The lifetime of NO in the tissues is quite short, a few seconds, but it lasts long enough to be effective. [Pg.79]

Given this structural similarity, it should not be surprising to learn that sulfanilamide competes with p-aminobenzoic acid for a binding site on the surface of dihydropteroate synthetase. Put another way, sulfanilamide binds to the enzyme where p-aminobenzoic acid should bind but no reaction occurs. The consequence is that a step in folic acid biosynthesis is disrupted and the bacterial cell is deprived of adequate folic acid. Nucleic acid synthesis, among other things, is disrupted, leading to a cessation of cell growth and division. The human immune system can mop up what remains. No similar consequences befall the human host since it cannot make folic acid in the first place and must get an adequate supply of this vitamin in the diet. [Pg.322]

Linezohd (Zyvox) is an oxazolidinone, a tive-membered heterocychc ring that forms the core of the hnezohd structure. The approval of hnezohd by the FDA in 2000 marked the first new structural class of antibacterial introduced into medical practice in the United States in 40 years. It is notable for its activity against methicillin-resistant Staph aureus, MRSA, and vancomycin-resistant Enterococcus faecium, VRE. It is bacteriostatic rather than bactericidal but finds significant use in patients with an intact immune system. Like several other classes of antibacterials, linezolid is an inhibitor of protein synthesis. It interacts specifically with the RNA component of a bacterial ribosome subunit to prevent initiation of protein synthesis. [Pg.328]

Figure 8.29 The initial reactions of glutamine metabolism in kidney, intestine and cells of the immune system. The initial reaction in all these tissues is the same, glutamine conversion to glutamate catalysed by glutaminase the next reactions are different depending on the function of the tissue or organ. In the kidney, glutamate dehydrogenase produces ammonia to buffer protons. In the intestine, the transamination produces alanine for release and then uptake and formation of glucose in the liver. In the immune cells, transamination produces aspartate which is essential for synthesis of pyrimidine nucleotides required for DNA synthesis otherwise it is released into the blood to be removed by the enterocytes in the small intestine or by cells in the liver. Figure 8.29 The initial reactions of glutamine metabolism in kidney, intestine and cells of the immune system. The initial reaction in all these tissues is the same, glutamine conversion to glutamate catalysed by glutaminase the next reactions are different depending on the function of the tissue or organ. In the kidney, glutamate dehydrogenase produces ammonia to buffer protons. In the intestine, the transamination produces alanine for release and then uptake and formation of glucose in the liver. In the immune cells, transamination produces aspartate which is essential for synthesis of pyrimidine nucleotides required for DNA synthesis otherwise it is released into the blood to be removed by the enterocytes in the small intestine or by cells in the liver.
They are precursors for the synthesis of glucose via glu-coneogenesis that is required for the increased number and activity of cells of the immune system, for those involved in repair (e.g. fibroblasts) and for the brain, especially if the patient cannot feed. [Pg.423]

The presence of a certain number of amino acids is significant for the restitution of the immune system s cells, interferon synthesis process and other factors realization of the immune defense system. The decrease of full-form protein consumption is one of the causes of secondary immune-deficiency states. The significance of ascorbic acid presence for the immune system is supported by the fact that its concentration in the neutrophil granulocytes is 150 times higher than in the blood serum. The significance of retinol s and carotenoids role is supported in the cases of cell differentiation, where DNA synthesis increase, and proliferation decrease thus stabilizing the organism when under infection. [Pg.417]


See other pages where Immune system synthesis is mentioned: [Pg.430]    [Pg.430]    [Pg.430]    [Pg.1004]    [Pg.545]    [Pg.590]    [Pg.643]    [Pg.437]    [Pg.483]    [Pg.591]    [Pg.253]    [Pg.1519]    [Pg.102]    [Pg.768]    [Pg.209]    [Pg.241]    [Pg.478]    [Pg.356]    [Pg.368]    [Pg.492]    [Pg.510]    [Pg.180]    [Pg.42]    [Pg.145]    [Pg.544]    [Pg.261]    [Pg.256]    [Pg.162]    [Pg.164]    [Pg.165]    [Pg.193]    [Pg.323]    [Pg.104]    [Pg.1565]   


SEARCH



Antibody synthesis Immune system

Immune systems

© 2024 chempedia.info